Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

130.08
Delayed Data
As of 3:59pm ET
 +0.92 / +0.71%
Today’s Change
92.03
Today|||52-Week Range
132.95
+15.44%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close129.16
Today’s open130.04
Day’s range129.40 - 130.79
Volume177,989
Average volume (3 months)360,196
Market cap$5.6B
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.53%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+43.09%
P/E ratio121.6
Price/Sales12.92
Price/Book14.92

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+1.13+1.36%
MASIMasimo Corp+1.09+1.09%
DXCMDexCom Inc+0.74+0.99%
NUVANuVasive Inc-2.88-3.74%
Data as of 4:02pm ET, 04/26/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs